How I conduct a comprehensive chronic graft-versus-host disease assessment

Blood

Volumn 118, Issue 10, 2011, Pages 2679-2687

  Carpenter, Paul A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ASSESSMENT TOOL; DISEASE CLASSIFICATION; DISEASE COURSE; ENTERITIS; ERYTHEMA; GENITAL SYSTEM EXAMINATION; HUMAN; HYPERPIGMENTATION; LABORATORY TEST; MEDICAL HISTORY; MORPHEA; PATIENT ASSESSMENT; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANGE OF MOTION; SKIN EXAMINATION;

EID: 80052683661     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-314815     Document Type: Article

References (14)

1. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945-956. (Pubitemid 41754712)
2. Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant. 2006;12(1):31-47. (Pubitemid 43034096)
3. Martin PJ, Weisdorf D, Przepiorka D, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant. 2006;15(5):491-505. (Pubitemid 43956368)
4. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant. 2006;12(3):252-266. (Pubitemid 43273710)
5. http://clinicaltrials.gov/ct2/show/NCT01106833. Accessed April 19, 2009.
6. http://www.fhcrc.org/science/clinical/gvhd. Accessed April 19, 2009.
7. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-217. (Pubitemid 10036817)
8. Treister NS, Stevenson K, Kim H, et al. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant. 2010;16(1):108-114.
9. Mitchell SA, Jacobsohn DA, Thormann KE, et al. A multi-center pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change [published online ahead of print April 12, 2011]. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2011.04.002.
10. Liker JK. The Toyota Way: 14 Management Principles From the World's Greatest Manufacturer. New York, NY: McGraw-Hill; 2004.
11. Greinix HT, Pohlreich D, Maalouf J, et al. A single-center pilot validation study of a new chronic GVHD skin scoring system. Biol Blood Marrow Transplant. 2007;13(6):715-723. (Pubitemid 46768000)
12. Furst DE, Clements PJ, Steen VD, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25(1):84-88. (Pubitemid 28060123)
13. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281-1285.
14. Khanna D, Furst DE, Hays RD, et al. Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis. 2006;65(10):1325-1329. (Pubitemid 44620441)